Acadia Pharmaceuticals Inc. ACAD
$28.02
+0.57%
at last close
Analyst Consensus
- Consensus Rating
- Buy (14 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $35.12
- Implied Upside
- +25.3%
- Price Target Range
- $25.00 – $49.00
- Analysts (12 mo)
- 17
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-25 | Deutsche BankDavid Hoang |
Maintains | Buy | $37 → $38 |
| 2026-08-25 | Morgan StanleyJeffrey Hung |
Maintains | Equal-weight | $27 → $28 |
| 2026-08-25 | CitigroupYigal Nochomovitz |
Maintains | Buy | $39 → $40 |
| 2026-08-17 | UBSAshwani Verma |
Maintains | Buy | $45 → $49 |
| 2026-08-12 | NeedhamAmi Fadia |
Maintains | Buy | $38 → $41 |
| 2026-08-10 | CitigroupYigal Nochomovitz |
Maintains | Buy | $35 → $39 |
| 2026-08-05 | OppenheimerMatthew Hershenhorn |
Maintains | Perform | $23 → $25 |
| 2026-08-05 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $36 → $37 |
| 2026-08-05 | CitizensJason N. Butler |
Maintains | Market outperform | $35 → $36 |
| 2026-07-21 | BMO CapitalEvan David Seigerman |
Maintains | Outperform | $34 → $36 |
| 2026-07-21 | StifelPaul Matteis |
Maintains | Hold | $24 → $25 |
| 2026-07-07 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $29 → $36 |
| 2026-06-30 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $29 → $30 |
| 2026-06-29 | CitigroupYigal Nochomovitz |
Maintains | Buy | $32 → $35 |
| 2026-06-29 | Canaccord GenuitySumant Kulkarni |
Maintains | Buy | $32 → $36 |
| 2026-05-08 | CitigroupYigal Nochomovitz |
Maintains | Buy | $33 → $32 |
| 2026-03-25 | B of A SecuritiesTazeen Ahmad |
Upgrades | Neutral → Buy | $29 |
| 2026-03-04 | JP MorganTessa Romero |
Maintains | Overweight | $31 → $34 |
| 2026-02-26 | TD CowenRitu Baral |
Maintains | Buy | $35 → $37 |
| 2026-02-26 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $31 → $30 |
| 2026-02-26 | CitizensJason N. Butler |
Maintains | Market outperform | $34 → $35 |
| 2026-02-26 | StifelPaul Matteis |
Maintains | Hold | $25 → $24 |
| 2026-02-24 | Wolfe ResearchRudy Li |
Initiates coverage on | Outperform | $33 |
| 2026-02-23 | MizuhoUy Ear |
Upgrades | Neutral → Outperform | $29 → $35 |
| 2026-02-06 | OppenheimerJay Olson |
Maintains | Perform | $21 → $23 |
| 2026-02-03 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $35 → $31 |
| 2026-02-03 | CitizensJason N. Butler |
Reiterates | Market outperform | $34 |
| 2026-02-03 | HC Wainwright & Co.Ananda Ghosh |
Reiterates | Buy | $37 |
| 2026-01-06 | CitigroupYigal Nochomovitz |
Maintains | Buy | $33 → $36 |
| 2026-01-06 | UBSAshwani Verma |
Maintains | Buy | $35 → $40 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $28.02
- Market Cap
- $4.83 billion
- 52-Week Range
- $19.69 – $30.96
- Average Volume
- 1.66 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.